These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16401719)

  • 21. Rasburicase for huge hepatocellular carcinoma with tumor lysis syndrome: case report.
    Chao CT; Chiang CK
    Med Princ Pract; 2012; 21(5):498-500. PubMed ID: 22687814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting vessels to treat hepatocellular carcinoma.
    Romanque P; Piguet AC; Dufour JF
    Clin Sci (Lond); 2008 Apr; 114(7):467-77. PubMed ID: 18302534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma.
    Krishnan G; D'Silva K; Al-Janadi A
    J Clin Oncol; 2008 May; 26(14):2406-8. PubMed ID: 18467734
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma.
    Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F
    Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin.
    Kampitak T
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):929-30. PubMed ID: 18278497
    [No Abstract]   [Full Text] [Related]  

  • 26. Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia.
    Moutouh-de Parseval LA; Weiss L; DeLap RJ; Knight RD; Zeldis JB
    J Clin Oncol; 2007 Nov; 25(31):5047. PubMed ID: 17971612
    [No Abstract]   [Full Text] [Related]  

  • 27. Angiogenesis and anti-angiogenesis in hepatocellular carcinoma.
    Ribatti D; Vacca A; Nico B; Sansonno D; Dammacco F
    Cancer Treat Rev; 2006 Oct; 32(6):437-44. PubMed ID: 16870349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypoxia in hepatocellular carcinoma].
    Myung SJ; Yoon JH
    Korean J Hepatol; 2007 Mar; 13(1):9-19. PubMed ID: 17380070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oesophageal variceal bleeding in hepatocellular carcinoma with portal vein thrombosis: improved outcome in response to molecular target therapy.
    Wu SS; Yen HH; Chung CY
    Clin Oncol (R Coll Radiol); 2008 Sep; 20(7):566-7. PubMed ID: 18555670
    [No Abstract]   [Full Text] [Related]  

  • 30. [Paraneoplastic hypoglycemia in liver-cell carcinoma. Nadler Wolfer Elliott syndrome].
    Krönig B; Baas EU
    Dtsch Med Wochenschr; 1973 Feb; 98(7):322-5. PubMed ID: 4119615
    [No Abstract]   [Full Text] [Related]  

  • 31. Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide.
    Patt YZ; Hassan MM; Lozano RD; Ellis LM; Peterson JA; Waugh KA
    Am J Clin Oncol; 2000 Jun; 23(3):319-21. PubMed ID: 10857902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic arterial infusion chemotherapy with epirubicin in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Iwasa S; Hagihara A; Kojima Y
    Oncology; 2007; 72(3-4):188-93. PubMed ID: 18097170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of hepatocellular carcinoma with liver cirrhosis type C surviving over 2 years by repeated transarterial infusion therapy using cisplatinum].
    Miura T; Tsuboi Y; Takano T; Ozeki Y; Nakamura J; Yamada S; Miura T; Yanagi M; Takahashi T
    Gan To Kagaku Ryoho; 2009 Aug; 36(8):1347-9. PubMed ID: 19692776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encephalopathy in a patient after long-term treatment with thalidomide.
    Sohlbach K; Heinze S; Shiratori K; Sure U; Pagenstecher A; Neubauer A
    J Clin Oncol; 2006 Oct; 24(30):4942-4. PubMed ID: 17050881
    [No Abstract]   [Full Text] [Related]  

  • 35. Successful targeted therapies for hepatocellular carcinoma: are we really getting there?
    Zhu AX
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):499-505. PubMed ID: 18402516
    [No Abstract]   [Full Text] [Related]  

  • 36. Hepatocellular carcinoma in a young survivor of major burns.
    Harper A; Rea S; Wood F
    Burns; 2008 Jun; 34(4):572-4. PubMed ID: 18082962
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampicin as an oral angiogenesis inhibitor targeting hepatic cancers.
    Shichiri M; Fukai N; Kono Y; Tanaka Y
    Cancer Res; 2009 Jun; 69(11):4760-8. PubMed ID: 19458074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous tumour lysis syndrome.
    Kekre N; Djordjevic B; Touchie C
    CMAJ; 2012 May; 184(8):913-6. PubMed ID: 22496380
    [No Abstract]   [Full Text] [Related]  

  • 40. [Angiogenesis inhibitor (TNP-470: AGM-1470)].
    Taniguchi H
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():678-82. PubMed ID: 11762036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.